A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-γ2 is associated with combined hyperlipidaemia in obesity

European Journal of Endocrinology

Volumn 144, Issue 3, 2001, Pages 277-282

  Swarbrick, M M ^a   Chapman, C M L ^a   McQuillan, B M ^a   Hung, J ^a   Thompson, P L ^a   Beilby, J P ^a  

^a PathCentre ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTICLE; AUSTRALIA; BIOCHEMISTRY; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERLIPIDEMIA; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; VENOUS BLOOD;

EID: 0035062772     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1440277     Document Type: Article

References (30)

1. Adipogenesis and obesity: Rounding out the big picture
2. mPPARγ2: Tissue-specific regulator of an adipocyte enhancer
3. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
4. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation
5. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension
6. Peroxisome proliferator-activated receptor gene expression in human tissues: Effects of obesity, weight loss and regulation by insulin and glucocorticoids
7. PPARγ3 mRNA: A distinct subtype transcribed from an independent promoter
8. Ligand-independent activation domain in the N-terminus of peroxisome proliferator-activated receptor γ (PPARγ)
9. Molecular screening of the human peroxisome proliferator-activated receptor γ (hPPARγ) gene in diabetic Caucasians: Identification of a Pro12Ala missense mutation
10. Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
11. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations
12. Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2): Divergent modulating effects on body mass index in obese and lean Caucasian men
13. Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women
14. Impact of the peroxisome proliferator activated receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus
15. The Pro12Ala variant of peroxisome proliferator-activated receptor-γ2 (PPAR-γ2) is associated with measures of obesity in Mexican Americans
16. The Pro12Ala polymorphism in PPARγ2 may confer resistance to type 2 diabetes
17. Pro12Ala missense mutation of the peroxisome proliferator-activated receptor γ and diabetes mellitus
18. Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes
19. Hyperhomocysteinaemia but not the C677T mutation of methelenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening: The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)
20. Age and secular trends in risk factors for cardiovascular disease in Busselton
21. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultrafuge
22. Mutagenically separated PCR (MS-PCR): A highly specific one step procedure for easy mutation detection
23. Review of new guidelines for management of dyslipidaemia
24. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)
25. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki heart study
26. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-γ2 on thiazolidinedione-induced adipogenesis
27. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
28. Lipoprotein lipase action determining plasma high density lipoprotein lipase cholesterol level in adult normolipidaemics
29. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation
30. Hyperinsulinaemia and abdominal obesity affect the expression of hypertriglyceridaemia in heterozygous familial lipoprotein lipase deficiency